Benzinga | Nov 11, 2021 04:27PM EST

Apyx Medical Q3 EPS $(0.12) Beats $(0.15) Estimate, Sales $11.80M Beat $10.20M Estimate

Apyx Medical (NASDAQ:APYX) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.15) by 20 percent. This is a 9.09 percent decrease over losses of $(0.11) per share from the same period last year. The company reported quarterly sales of $11.80 million which beat the analyst consensus estimate of $10.20 million by 15.69 percent. This is a 69.69 percent increase over sales of $6.95 million the same period last year.